BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,233,796 | +64.2% | 602,027 | +106.6% | 0.35% | +62.4% |
| Q2 2023 | $18,414,078 | +288.4% | 291,362 | +176.5% | 0.22% | +240.6% |
| Q1 2023 | $4,740,911 | -55.0% | 105,377 | -56.2% | 0.06% | -54.6% |
| Q4 2022 | $10,544,804 | +71.4% | 240,694 | +157.7% | 0.14% | +64.0% |
| Q3 2022 | $6,153,000 | +4.9% | 93,387 | -19.6% | 0.09% | -4.4% |
| Q2 2022 | $5,864,000 | +269.0% | 116,087 | +366.7% | 0.09% | +246.2% |
| Q1 2022 | $1,589,000 | -76.1% | 24,873 | -59.9% | 0.03% | -72.6% |
| Q4 2021 | $6,647,000 | -62.4% | 62,055 | -63.9% | 0.10% | -67.1% |
| Q3 2021 | $17,687,000 | +252.4% | 172,035 | +201.5% | 0.29% | +207.4% |
| Q2 2021 | $5,019,000 | -41.9% | 57,056 | -35.8% | 0.09% | -51.0% |
| Q1 2021 | $8,644,000 | – | 88,906 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |